GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 14, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
2O1L | P24627 | Structure of a complex of C-terminal lobe of bovine lactoferrin with disaccharide at 1.97 A resolution | |
2O1D | P39116 | Pectate lyase bound to trisaccharide | |
2O17 | P39116 | Pectate lyase bound to hexasaccharide | |
2O0V | P39116 | Pectate lyase bound to hexasaccharide compound III | |
2O04 | P39116 | Pectate lyase bound to hexasaccharide compound II | |
2NZY | O30511 | Crystal Structure of alpha1,3-Fucosyltransferase with GDP-fucose | |
2NZV | P46828 | Structural mechanism for the fine-tuning of CcpA function by the small molecule effectors G6P and FBP | |
2NZV | O69250 | Structural mechanism for the fine-tuning of CcpA function by the small molecule effectors G6P and FBP | |
2NZU | P46828 | Structural mechanism for the fine-tuning of CcpA function by the small molecule effectors G6P and FBP | |
2NZU | O69250 | Structural mechanism for the fine-tuning of CcpA function by the small molecule effectors G6P and FBP | |
2NZT | P52789 | Crystal structure of human hexokinase II | |
2NZM | P39116 | Hexasaccharide I bound to Bacillus subtilis pectate lyase | |
2NZ4 | P09012 | Structural investigation of the GlmS ribozyme bound to its catalytic cofactor | |
2NYK | Q6XK79 | Crystal structure of m157 from mouse cytomegalovirus | |
2NY7 | P04578 | HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 | |
2NY7 | 2NY7 | HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody b12 | |
2NY6 | Q8Q7Z9 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
2NY6 | P01730 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
2NY6 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
2NY6 | Q6N030 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) Complexed with CD4 and Antibody 17b | |
2NY5 | P01730 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY5 | Q71057 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY5 | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY5 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) Complexed with CD4 and Antibody 17b | |
2NY4 | Q8QDX5 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY4 | P01730 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY4 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY4 | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E268C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY3 | Q993A8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY3 | P01730 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY3 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY3 | Q6N030 | HIV-1 gp120 Envelope Glycoprotein (K231C, T257S, E267C, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NY2 | Q993A8 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY2 | P01730 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY2 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY2 | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (T123C, T257S, S334A, S375W, G431C) Complexed with CD4 and Antibody 17b | |
2NY1 | Q993A8 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
2NY1 | P01730 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
2NY1 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
2NY1 | Q6N030 | HIV-1 gp120 Envelope Glycoprotein (I109C, T257S, S334A, S375W, Q428C) Complexed with CD4 and Antibody 17b | |
2NY0 | Q8QDX5 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NY0 | P01730 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NY0 | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NY0 | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (M95W, W96C, T257S, V275C, S334A, S375W, A433M) Complexed with CD4 and Antibody 17b | |
2NXZ | Q8QDX5 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NXZ | P01730 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NXZ | Q6P5S8 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NXZ | Q6PJA4 | HIV-1 gp120 Envelope Glycoprotein (T257S, S334A, S375W) Complexed with CD4 and Antibody 17b | |
2NXY | Q49DS8 | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b | |
2NXY | P01730 | HIV-1 gp120 Envelope Glycoprotein(S334A) Complexed with CD4 and Antibody 17b |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024